|
Published by: iData Research, Inc.
Published: Mar. 1, 2009 - 96 Pages
Table of Contents
- LIST OF FIGURES
- LIST OF CHARTS
- EXECUTIVE SUMMARY
- 1.1 PSORIASIS TREATMENT MARKET
- 1.2 PSORIASIS TREATMENT UTILIZATION
- 1.3 COMPETITIVE ANALYSIS
- RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATA’S 9-STEP METHODOLOGY
- 2.2.1 Step 1: Project Initiation & Team Selection
- 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
- 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
- 2.2.4 Step 4: Performing Primary Research
- 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
- 2.2.6 Step 6: Market Forecast and Analysis
- 2.2.7 Step 7: Identify Strategic Opportunities
- 2.2.8 Step 8: Final Review and Market Release
- 2.2.9 Step 9: Customer Feedback and Market Monitoring
- PSORIASIS CREAM AND MEDICATION MARKET
- 3.1 INTRODUCTION
- 3.1.1 Status of Pharmacotherapy in Psoriasis
- 3.1.1.1 Topical Treatments
- 3.1.1.2 Non-Biologic Systemic Treatments
- 3.1.1.3 Biologic Systemic Treatments
- 3.2 MARKET OVERVIEW
- 3.2.1 Psoriasis Patient Population
- 3.2.1.1 Number of Treatments per Patient
- 3.2.2 Psoriasis Treatment Utilization
- 3.2.3 Psoriasis Treatment Prices
- 3.3 MARKET ANALYSIS AND FORECAST
- 3.3.1 Combined Market
- 3.3.2 Market for Topical Psoriasis Treatments
- 3.3.3 Market for Biologic Treatments
- 3.3.4 Market for Non-Biologic Systemic Treatments
- 3.4 MARKET DRIVERS AND LIMITERS
- 3.4.1 Market Drivers
- 3.4.2 Market Limiters
- 3.5 COMPETITIVE ANALYSIS
- 3.5.1 Total Psoriasis Treatment Competitive Analysis
- 3.5.2 Topical Treatment Competitive Analysis
- 3.5.3 Biologic Treatment Competitive Analysis
- 3.5.4 Non-Biologic Systemic Treatment Competitive Analysis
- ABBREVIATIONS
- LIST OF FIGURES
- EXECUTIVE SUMMARY
- RESEARCH METHODOLOGY
- PSORIASIS CREAM AND MEDICATION MARKET
- Figure 3-1: Psoriasis Patient Population, U.S., 2005 - 2005
- Figure 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 - 2015 . 26
- Figure 3-3: Diagnosis Rates by Psoriasis Severity, U.S., 2005 - 2015
- Figure 3-4: Psoriasis Severity Treatment Rates, U.S., 2005 - 2015
- Figure 3-5: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 -
- 2015
- Figure 3-6: Psoriasis Treatment Utilization Frequency, U.S., 2005 - 2015
- Figure 3-7: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2005 -
- 2015
- Figure 3-8: Psoriasis Treatment Monthly Prices by Treatment Type, U.S., 2005 -
- 2015
- Figure 3-9: Total Market for Psoriasis Treatments, U.S., 2005 - 2015
- Figure 3-10: Total Market for Psoriasis Treatments by Treatment Type, U.S.,
- 2005 - 2015
- Figure 3-11: Market for Topical Psoriasis Treatments, U.S., 2005 - 2015
- Figure 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,
- 2005 - 2015
- Figure 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 - 2015
- Figure 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005
- - 2015
- Figure 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by
- Treatment Type, U.S., 2005 - 2015
- Figure 3-16: Drivers and Limiters, Psoriasis Market, U.S., 2008
- Figure 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S.,
- 2008
- Figure 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment
- Market, U.S., 2008
- Figure 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market,
- U.S., 2008
- Figure 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis
- Treatment Market, U.S., 2008
- ABBREVIATIONS
- LIST OF CHARTS
- EXECUTIVE SUMMARY
- Chart 1-1: Anti-Adhesion Product Market, U.S., 2005 - 2015
- Chart 1-2: Psoriasis Treatment Utilization, U.S., 2008
- Chart 1-3: Leading Competitors in the Psoriasis Treatment Market, U.S., 2008
- RESEARCH METHODOLOGY
- PSORIASIS CREAM AND MEDICATION MARKET
- Chart 3-1: Psoriasis Patient Population by Disease Severity, U.S., 2008
- Chart 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 - 2015
- Chart 3-3: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 -
- 2015
- Chart 3-4: Psoriasis Treatment Utilization Frequency, U.S., 2008
- Chart 3-5: Psoriasis Treatment Utilization Frequency, U.S., 2015
- Chart 3-6: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2008
- Chart 3-7: Total Market for Psoriasis Treatments, U.S., 2005 - 2015
- Chart 3-8: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2008
- (US$ Millions)
- Chart 3-9: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2015
- (US$ Millions)
- Chart 3-10: Market for Topical Psoriasis Treatments, U.S., 2005 - 2015
- Chart 3-11: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,
- 2008 (US$ Millions)
- Chart 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,
- 2015 (US$ Millions)
- Chart 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 - 2015
- Chart 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005
- - 2015
- Chart 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by
- Treatment Type, U.S., 2008
- Chart 3-16: Market for Non-Biologic Systemic Psoriasis Treatments by
- Treatment Type, U.S., 2015 (US$ Millions)
- Chart 3-17: Leading Competitors in the Total Psoriasis Treatment Market, U.S.,
- 2008
- Chart 3-18: Leading Competitors in the Prescription Topical Psoriasis Treatment
- Market, U.S., 2008
- Chart 3-19: Leading Competitors in the Biologic Psoriasis Treatment Market,
- U.S., 2008
- Chart 3-20: Leading Competitors in the Non-Biologic Systemic Psoriasis
- Treatment Market, U.S., 2008
- ABBREVIATIONS
AbstractThe psoriasis treatment market includes all over-the-counter and prescription pharmaceutical products used to treat psoriasis. This includes topical tar, salicylic acid, corticosteroids, combination corticosteroids, vitamin D analogs, anthralin, retinoids, methotrexate, cyclosporine, and biologic treatments. Over the forecast period, the market is estimated to increase at double digit rates.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
